The impact of pharmacoeconomic assessment on national formulary decisions: a comparative analysis of three Asian Pacific countries and three European countries


OccasionWorking Conference HSR in Europe
CountriesFrance, Germany, United Kingdom, Australia, Singapore
SectorsGeneral health
Last update date09-20-2011 11:25


Download / print this document - Share this material: Facebook | TwitterManage this material?

Want to manage this material?


Do you think you are allowed to manage this material? Submit this form and we will verify if you're right.


You have to login (or register first) before you can manage this material.

Log in


With the form below you can log in to this website and add materials. If you are a new user and want to create an account please register here.


Fields with * are required